Blue Owl Capital Holdings LP
Filing Date
Global Rank
#3,129
/ 8,622
▲ 306
· as of Mar 2026
Top Industry
Biotechnology
74.4%
3Y Alpha vs SPY
-11.7%
Period ended 4 months ago
Filed May 14, 2026 · 3mo
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+23.1%
SPY
+67.9%
Annualised alpha
-11.7%
Max drawdown
−46.7%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
45 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
15.7%
+6.0 pts
Top 5
48.0%
+5.0 pts
Top 10
71.6%
+8.0 pts
HHI
668
Diversified+146
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 77.2% | $278,376,738 |
| Financial Services | 14.2% | $51,326,645 |
| Consumer Cyclical | 4.9% | $17,782,614 |
| Technology | 2.5% | $9,007,241 |
| Real Estate | 0.8% | $2,730,144 |
| Energy | 0.4% | $1,286,804 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | +1,055,416 | 4,416,353 | $30,075,363 | |
| AQST | Aquestive Therapeutics, Inc. | +822,932 | 1,347,932 | $5,593,917 | |
| MPLT | MapLight Therapeutics, Inc. | +678,871 | 1,005,929 | $20,450,536 | |
| EYPT | EyePoint, Inc. | +520,000 | 912,594 | $11,763,336 | |
| LENZ | LENZ Therapeutics, Inc. | +356,722 | 506,722 | $4,636,506 | |
| LRMR | Larimar Therapeutics, Inc. | +296,317 | 7,120,007 | $32,040,031 | |
| CNDT | CONDUENT Inc | +214,173 | 5,036,595 | $6,446,841 | |
| IMA | ImageneBio, Inc. | +135,552 | 959,337 | $4,796,685 | |
| HLLY | Holley Inc. | +90,252 | 4,236,888 | $13,007,246 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +90,000 | 302,638 | $6,340,266 | |
| PIPR | Piper Sandler Companies | +1,821 | 2,428 | $185,863 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | −2,343,891 | 5,089,015 | $13,333,219 | |
| SGMT | Sagimet Biosciences Inc. | −910,000 | 333,877 | $1,744,507 | |
| CMPX | Compass Therapeutics, Inc. | −525,000 | 2,941,525 | $15,560,667 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −510,000 | 1,419,912 | $4,373,328 | |
| CGEM | Cullinan Therapeutics, Inc. | −441,208 | 1,909,764 | $27,137,746 | |
| IMMX | Immix Biopharma, Inc. | −438,688 | 547,552 | $4,988,198 | |
| ORIC | Oric Pharmaceuticals, Inc. | −365,000 | 150,000 | $1,900,500 | |
| CVEO | Civeo Corp | −190,055 | 180,475 | $4,775,368 | |
| KALV | KalVista Pharmaceuticals, Inc. | −145,000 | 215,000 | $4,327,950 | |
| DELL | Dell Technologies Inc. | −39,949 | 13,899 | $2,281,242 | |
| PVLA | Palvella Therapeutics, Inc. | −9,000 | 31,259 | $3,896,434 | |
| AEON | AEON Biopharma, Inc. | −1,042 | 42,353 | $41,717 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 3,161,348 | $56,556,515 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 545,000 | $7,973,350 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 61,455 | $5,344,741 | |
| OVID | Ovid Therapeutics Inc. | 1,904,666 | $4,228,358 | |
| STWD | Starwood Property Trust, Inc. | 158,545 | $2,730,144 | |
| EVMN | Evommune, Inc. | 100,000 | $2,299,000 | |
| WW | Ww International, Inc. | 95,634 | $1,314,011 | |
| ET | Energy Transfer LP | 5,326 | $102,791 | |
| CAI | Caris Life Sciences, Inc. | 4,711 | $84,232 | |
| GOCOQ | GoHealth, Inc. | 40,770 | $61,562 | |
| KPLT | Katapult Holdings, Inc. | 5,421 | $38,272 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCOR | Procore Technologies, Inc. | 94,264 | $6,856,762 | |
| ROIV | Roivant Sciences Ltd. | 263,249 | $5,712,503 | |
| PAYO | Payoneer Global Inc. | 832,810 | $4,680,392 | |
| IMRX | Immuneering Corp | 665,000 | $4,375,700 | |
| CNTA | Centessa Pharmaceuticals plc | 139,450 | $3,487,644 | |
| CMPS | COMPASS Pathways plc | 469,914 | $3,242,406 | |
| NU | Nu Holdings Ltd. | 173,873 | $2,910,634 | |
| MLYS | Mineralys Therapeutics, Inc. | 65,944 | $2,393,107 | |
| JANX | Janux Therapeutics, Inc. | 100,000 | $1,380,000 | |
| CHYM | Chime Financial, Inc. | 39,886 | $1,003,930 | |
| OMDA | Omada Health, Inc. | 15,377 | $242,649 | |
| TTAN | ServiceTitan, Inc. | 2,266 | $241,329 | |
| BLNE | Beeline Holdings, Inc. | 129,529 | $222,789 | |
| ANGX | Angel Studios, Inc. | 10,000 | $46,700 | |
| No positions match the current search. | ||||
45 tracked positions ·
$360,510,186 total
· filing declares
76 positions · $372,172,997
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 3,161,348 | $56,556,515 | 15.69% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Reduced | 7,120,007 | $32,040,031 | 8.89% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Added | 4,416,353 | $30,075,363 | 8.34% | |
| NCDL |
Nuveen Churchill Direct Lending Corp.
Financial Services
|
Held | 2,143,626 | $27,266,922 | 7.56% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Reduced | 1,909,764 | $27,137,746 | 7.53% | |
| OBDC |
Blue Owl Capital Corp
Financial Services
|
Held | 2,045,070 | $22,618,474 | 6.27% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Added | 1,005,929 | $20,450,536 | 5.67% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 2,941,525 | $15,560,667 | 4.32% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Reduced | 5,089,015 | $13,333,219 | 3.70% | |
| HLLY |
Holley Inc.
Consumer Cyclical
|
Added | 4,236,888 | $13,007,246 | 3.61% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 912,594 | $11,763,336 | 3.26% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 545,000 | $7,973,350 | 2.21% | |
| CNDT |
CONDUENT Inc
Technology
|
Added | 5,036,595 | $6,446,841 | 1.79% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 302,638 | $6,340,266 | 1.76% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Added | 1,347,932 | $5,593,917 | 1.55% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 61,455 | $5,344,741 | 1.48% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Reduced | 547,552 | $4,988,198 | 1.38% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Added | 959,337 | $4,796,685 | 1.33% | |
| CVEO |
Civeo Corp
Consumer Cyclical
|
Reduced | 180,475 | $4,775,368 | 1.32% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Added | 506,722 | $4,636,506 | 1.29% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,419,912 | $4,373,328 | 1.21% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Reduced | 215,000 | $4,327,950 | 1.20% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
NEW | 1,904,666 | $4,228,358 | 1.17% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Reduced | 31,259 | $3,896,434 | 1.08% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 2,969,199 | $3,741,190 | 1.04% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Held | 733,568 | $2,750,880 | 0.76% | |
| STWD |
Starwood Property Trust, Inc.
Real Estate
|
NEW | 158,545 | $2,730,144 | 0.76% | |
| EVMN |
Evommune, Inc.
Healthcare
|
NEW | 100,000 | $2,299,000 | 0.64% | |
| DELL |
Dell Technologies Inc.
Technology
|
Reduced | 13,899 | $2,281,242 | 0.63% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 150,000 | $1,900,500 | 0.53% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
Reduced | 333,877 | $1,744,507 | 0.48% | |
| WW |
Ww International, Inc.
Healthcare
|
NEW | 95,634 | $1,314,011 | 0.36% | |
| EPD |
Enterprise Products Partners L.P.
Energy
|
Held | 31,290 | $1,184,013 | 0.33% | |
| FLD |
Fold Holdings, Inc.
Financial Services
|
Held | 856,632 | $1,130,754 | 0.31% | |
| MRKR |
Marker Therapeutics, Inc.
Healthcare
|
Held | 554,250 | $720,525 | 0.20% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Held | 1,718 | $363,030 | 0.10% | |
| PIPR |
Piper Sandler Companies
Financial Services
|
Added | 2,428 | $185,863 | 0.05% | |
| AMOD |
Alpha Modus Holdings, Inc.
Technology
|
Held | 394,078 | $145,020 | 0.04% | |
| ET |
Energy Transfer LP
Energy
|
NEW | 5,326 | $102,791 | 0.03% | |
| DAIC |
CID Holdco, Inc.
Technology
|
Held | 557,361 | $95,866 | 0.03% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
NEW | 4,711 | $84,232 | 0.02% | |
| SHFS |
SHF Holdings, Inc.
Financial Services
|
Held | 75,897 | $63,070 | 0.02% | |
| GOCOQ |
GoHealth, Inc.
Financial Services
|
NEW | 40,770 | $61,562 | 0.02% | |
| AEON |
AEON Biopharma, Inc.
Healthcare
|
Reduced | 42,353 | $41,717 | 0.01% | |
| KPLT |
Katapult Holdings, Inc.
Technology
|
NEW | 5,421 | $38,272 | 0.01% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.